Skip to main content
Equibles

MORGAN STANLEY

Position in CRDF — Cardiff Oncology, Inc.

CIK 895421 NEW YORK, NY
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$319,922
+$228,710 QoQ
Shares Held
246,095
+337.1% QoQ
Ownership
0.316%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 104 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. CRDF ranks #298 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CRDF

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $319,922 246,095
2026-03-31 $91,212 56,306
2025-12-31 $662,690 235,834
2025-09-30 $639,954 310,659
2025-06-30 $2,506,597 795,746
2025-03-31 $2,193,376 698,528
2024-12-31 $2,353,965 542,389
2024-09-30 $1,330,036 498,142
2024-06-30 $1,139,356 513,224
2024-03-31 $424,128 79,425
2023-12-31 $22,555 15,240
2023-09-30 $26,408 19,000
2023-06-30 $23,096 15,713
2023-03-31 $336,348 203,848
2022-12-31 $393,072 280,766
2022-09-30 $580,171 376,736
2022-06-30 $800,180 363,719
2022-03-31 $524,405 211,454
2021-12-31 $3,311,352 550,974
2021-09-30 $719,944 108,100
2021-06-30 $3,108,614 467,461
2021-03-31 $235,101 25,389
2020-12-31 $312,503 17,371
2020-09-30 $164,886 11,620
2020-06-30 $121,938 24,339